Chantix
Product Images NDC 21695-633

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 21695-633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (F990eca6 Fe6f 4423 A118 4b7b970995a1 01)

FDA Label Image

Figure 1 (F990eca6 Fe6f 4423 A118 4b7b970995a1 02)

FDA Label Image

Figure 2 (F990eca6 Fe6f 4423 A118 4b7b970995a1 03)

FDA Label Image

Figure 3 (F990eca6 Fe6f 4423 A118 4b7b970995a1 04)

FDA Label Image

Company Logo (F990eca6 Fe6f 4423 A118 4b7b970995a1 05)

This text is a distribution statement for Pfizer Labs, a division of Pfizer Inc, located in NY, NY 10017.*

FDA Label Image

Company Logo (F990eca6 Fe6f 4423 A118 4b7b970995a1 06)

This is a distributor information for Pfizer Labs Division of Pfizer Inc. NY, NY 10017.*

FDA Label Image

Chantix 0.5mg (F990eca6 Fe6f 4423 A118 4b7b970995a1 07)

Chantix is a medication used for smoking cessation, distributed by Physician Partner, T. Each tablet contains 0.85mg varenicline tartrate, equivalent to 0.5mg varenicline free base. The tablets are white to off-white, film-coated and biconvex, debossed by "Pfizer" on one side and "CHX 0.5" on another side. The product ID is RC063356, and it is manufactured by Pfizer Ireland Pharmaceuticals, Dublin, Ireland. The storage temperature range is 15°-30°C (59-86°F). The available text does not provide further information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.